Department of Nutrition, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui230032, People's Republic of China.
Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, People's Republic of China.
Public Health Nutr. 2023 Dec;26(12):2936-2944. doi: 10.1017/S1368980023001970. Epub 2023 Oct 9.
OBJECTIVE: Inflammation plays a critical role in the progression of chronic liver diseases, and diet can modulate inflammation. Whether an inflammatory dietary pattern is associated with higher risk of hepatic steatosis or fibrosis remains unclear. We aimed to investigate the associations between inflammatory dietary pattern and the odds of hepatic steatosis and fibrosis. DESIGN: In this nationwide cross-sectional study, diet was measured using two 24-h dietary recalls. Empirical dietary inflammatory pattern (EDIP) score was derived to assess the inflammatory potential of usual diet, which has been validated to highly predict inflammation markers in the study population. Controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) were derived from FibroScan to define steatosis and fibrosis, respectively. SETTING: US National Health and Nutrition Examination Survey. PARTICIPANTS: 4171 participants aged ≥18 years. RESULTS: A total of 1436 participants were diagnosed with S1 steatosis (CAP ≥ 274 dB/m), 255 with advanced fibrosis (LSM ≥ 9·7 kPa). Compared with those in the lowest tertile of EDIP-adherence scores, participants in the highest tertile had 74 % higher odds of steatosis (OR: 1·74, 95 % CI (1·26, 2·41)). Such positive association persisted among never drinkers, or participants who were free of hepatitis B and/or C. Similarly, EDIP was positively associated with CAP in multivariate linear model ( < 0·001). We found a non-significant association of EDIP score with advanced fibrosis or LSM ( = 0·837). CONCLUSIONS: Our findings suggest that a diet score that is associated with inflammatory markers is associated with hepatic steatosis. Reducing or avoiding pro-inflammatory diets intake might be an attractive strategy for fatty liver disease prevention.
目的:炎症在慢性肝病的进展中起着关键作用,而饮食可以调节炎症。炎症性饮食模式是否与肝脂肪变性或纤维化的风险增加有关尚不清楚。我们旨在研究炎症性饮食模式与肝脂肪变性和纤维化风险的相关性。
设计:在这项全国性的横断面研究中,饮食通过两次 24 小时膳食回忆来测量。经验性饮食炎症模式 (EDIP) 评分用于评估常用饮食的炎症潜力,该评分已在研究人群中得到验证,可高度预测炎症标志物。受控衰减参数 (CAP) 和肝硬度测量 (LSM) 分别来自 FibroScan 用于定义脂肪变性和纤维化。
地点:美国国家健康和营养调查。
参与者:4171 名年龄≥18 岁的参与者。
结果:共有 1436 名参与者被诊断为 S1 脂肪变性 (CAP≥274dB/m),255 名参与者患有晚期纤维化 (LSM≥9.7kPa)。与 EDIP 适应性得分最低三分位的参与者相比,最高三分位的参与者患脂肪变性的几率高 74% (OR:1.74,95%CI(1.26,2.41))。在从不饮酒者或无乙型肝炎和/或丙型肝炎的参与者中,这种正相关关系仍然存在。同样,EDIP 与多元线性模型中的 CAP 呈正相关 ( < 0.001)。我们发现 EDIP 评分与晚期纤维化或 LSM 无显著相关性 ( = 0.837)。
结论:我们的研究结果表明,与炎症标志物相关的饮食评分与肝脂肪变性有关。减少或避免摄入促炎饮食可能是预防脂肪肝疾病的一种有吸引力的策略。
BMC Gastroenterol. 2025-2-24
BMC Endocr Disord. 2023-4-20
J Hum Nutr Diet. 2022-10
J Hum Nutr Diet. 2022-10
Clin Gastroenterol Hepatol. 2022-6
Can J Gastroenterol Hepatol. 2021
Cancer Epidemiol Biomarkers Prev. 2021-4